|
ATG3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0962999999985E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.702700E-03 |
| Normal-vs-Stage2 |
4.304200E-02 |
| Normal-vs-Stage3 |
1.57557000000086E-05 |
| Normal-vs-Stage4 |
1.236430E-03 |
| Stage1-vs-Stage2 |
7.630000E-01 |
| Stage1-vs-Stage3 |
1.597920E-02 |
| Stage1-vs-Stage4 |
1.691010E-01 |
| Stage2-vs-Stage3 |
2.057200E-01 |
| Stage2-vs-Stage4 |
4.444200E-01 |
| Stage3-vs-Stage4 |
6.440200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25470000000594E-05 |
| Normal-vs-AfricanAmerican |
1.823030E-03 |
| Normal-vs-Asian |
3.908600E-01 |
| Caucasian-vs-AfricanAmerican |
4.407400E-01 |
| Caucasian-vs-Asian |
6.651600E-01 |
| AfricanAmerican-vs-Asian |
4.663400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.73850000027154E-07 |
| Normal-vs-Female |
2.405900E-02 |
| Male-vs-Female |
1.352060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.556200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.004720E-03 |
| Normal-vs-Age(61-80Yrs) |
8.42140000000269E-05 |
| Normal-vs-Age(81-100Yrs) |
1.59854999999265E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.880600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.741800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.129210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.971200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.497900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.353640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.514000E-01 |
| Normal-vs-Grade 2 |
2.518200E-03 |
| Normal-vs-Grade 3 |
4.9117999999515E-06 |
| Normal-vs-Grade 4 |
8.814800E-04 |
| Grade 1-vs-Grade 2 |
1.207170E-01 |
| Grade 1-vs-Grade 3 |
3.403700E-02 |
| Grade 1-vs-Grade 4 |
5.775700E-02 |
| Grade 2-vs-Grade 3 |
9.621800E-02 |
| Grade 2-vs-Grade 4 |
1.166760E-01 |
| Grade 3-vs-Grade 4 |
5.678600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.454100E-02 |
| Normal-vs-ccB subtype |
1.56646999999177E-05 |
| ccA subtype-vs-ccB subtype |
2.601900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.414100E-04 |
| Normal-vs-N1 |
6.102400E-01 |
| N0-vs-N1 |
6.962400E-01 |
|
|
